th lebanese society of medical oncology(lsmo ... program.pdfon behalf of the lebanese society of...

March 30 - 31, April 1, 2017PHOENICIA HOTEL - BEIRUT - LEBANON

in collaboration with:

14th

(LSMO)LEBANESE SOCIETY OFMEDICAL ONCOLOGYNATIONAL FORUM

Your Cancer Targetingwith the right arrow

Target Cancer with the Right Arrow

C M EA C C R E D I T E D

Fr eeRegistration

March 30 - 31, April 1, 2017 | PHOENICIA HOTEL - BEIRUT - LEBANON

14th LEBANESE SOCIETY OF MEDICAL ONCOLOGYNATIONAL FORUM

(LSMO)March 30 - 31, April 1, 2017 | PHOENICIA HOTEL - BEIRUT - LEBANON


(LSMO)





(LSMO)

Welcome Letter

Dear Colleagues and Friends,

On behalf of the Lebanese Society of Medical Oncology (LSMO), it is with a great pleasure that we invite you to attend the 14th Lebanese Society of Medical Oncology (LSMO) National Forum that will be held on March 30 - 31, April 1, 2017 at Phoenicia Hotel - Beirut, Lebanon.

We have put a cutting edge program that consist of educational sessions, updates, case presentations in a multidisciplinary approach. The congress will provide the opportunity to learn about novelties & actual tendencies of the field and will be delivered as by a group of leading experts from Europe and the Arab Countries.

As you enjoy the rich assortment of educational sessions, please take some time to visit our fascinating country and we ensure you that it will be the most rewarding and enjoyable experience!

We look forward to seeing you in Beirut!

Joseph Makdessi, MDLSMO President





(LSMO)

Scientific Committee LSMO Executive Board

Dani Abi Gerges, MD

Nizar Bitar, MD

Nabil Chamseddine, MD

Michel Daher, MD

Nuhad Doumit , MD

Fadi Geara, MD

Claude Ghorra, MD

Ahmad Ibrahim, MD

Joseph Kattan, MD

Raghid Khoury, MD

Joseph Makdessi, MD

Ghazi Nsouli, MD

Pascale Salameh, MD

Ali Shamseddine, MD

Arafat Tfayli, MD

Joseph Makdessi, MD President

Nizar Bitar, MDPresident Elect

Oussama Jradi, MD General Secretary

Adnan Atallah, MDTreasurer

Fadi El Karak, MDMember

Rita Murr, MD Member

Arafat Tfayli, MD Member





(LSMO)

Day 1 | Thursday 30 March, 2017

13:00 - 14:00 Lunch Break

14:00 - 15:00 Breast

14:00 - 14:20 New Approaches in Triple-Negative Breast Cancer: PARP Inhibitors and Beyond

Sanaa Al Sukhun

14:20 - 14:40 Role of Genomic Tools in Chemotherapy Decision for Early-Stage Breast Cancer

Nagi El Saghir

14:40 - 15:00 Adjuvant Hormonal Therapy Sanaa Al Sukhun

Moderator: Joseph Makdessi15:00 - 15:45 Current and Emerging Treatment Options for Breast

Cancer - Symposium NovartisMatti AaproJoseph Kattan

15:45 - 16:10 Coffee Break

16:10 - 16:55 Navigating the Future for HR+/HER2 - Metastatic Breast Cancer - Symposium Pfizer

Nabil ChamseddineFadi El Karak

16:55 - 17:30 20 years of HER2 Innovation Symposium Roche

Ghazi Nsouli

17:30 - 18:00 Opening Ceremony In Memory of Nader KassemFollowed by a Cocktail Reception





(LSMO)

Day 2 | Friday 31 March, 2017

09:00 - 10:30 Lung09:00 - 09:20 Screening in Lung Cancer Hassan Chami09:20 - 09:40 Lung cancer in 2020 Fadlo Khuri09:40 - 10:00 Cancer Gene Profiling : A Word of Caution Arafat Tfayli

10:00 - 10:20 Optimal Molecular Testing : Strategy in Lung Cancer Isabelle Soubeyran10:20 - 10:30 Discussion


Moderator: Georges Chahine10:50 - 12:00 Oxycodones: A New Era Supporting Patients in Pain

Symposium Mundipharma10:50 - 11:05 Alleviating Chronic Cancer Pain: Challenges & Opportunities Rana Yamout11:05 - 11:20 Importance of Pain Management in Cancer Patients Georges Chahine11:20 - 11:35 The Difficult Cancer Patient Hussein Abukhudair11:35 - 11:55 New Approach to MEC & HEC Management for CINV Patients Gianluca Ballineri11:55 - 12:00 Discussion

12:00 - 12:45 Optimizing the Treatment of NSCLC: Navigating a New Complexity in Treatment Selection and Patient Management - Symposium Lilly

Nick Tatcher

Moderator: Hady Ghanem12:45 - 13:15 Tagrisso: Target T790 Mutation in Lung Cancer

Symposium AstraZenecaArafat Tfayli


14:15 - 15:25 When the usual did not fit14:15 - 14:35 Intraarterial Chemotherapy Mustapha Tehfé14:35 - 14:55 Radio - Embolisation Abbas Shamseddine14:55 - 15:15 SBRT Irradiation in Liver Youssef Zeidan15:15 - 15:25 Discussion





(LSMO)

15:25 - 16:35 Navigating the Dynamic of Immuno-Oncology (I-O) in Urinary CancersSymposium BMS

15:25 - 15:30 Introduction Joseph Makdessi15:30 - 15:50 Bladder Cancers in Lebanon Ali Shamseddine15:50 - 16:30 Navigating the Dynamics of Immuno-Oncology (I-O) in

Urinary CancersRichard Cathomas

16:30 - 16:35 Discussion


16:55 - 18:25 Shifting Concept in Rectal Cancer Managements16:55 - 17:15 Total New Adjuvant Therapy in Rectal Cancer Ali Shamseddine17:15 - 17:35 Sphincter Preservation in Rectal Surgery Imad El Hajj17:35 - 17:55 Transanal Scopic Surgery Samer Deeba17:55 - 18:15 MSI Testing: NGS vs Immunohistochemistry Hampig Kourie

Carole Abou Nader18:15 - 18:25 Discussion

18:25 - 19:05 Symposium Takeda

Day 2 | Friday 31 March, 2017





(LSMO)

Day 3 | Saturday 01 April, 2017

09:00 - 10:30 Prostate09:00 - 09:20 Treatment Overview Alexandre de la Taille09:20 - 09:40 MRI Fusion Biopsy Bernard Malavau09:40 - 10:00 PSMA as a Novel Target for Prostate Cancer Imaging and

TreatmentMohamed Haidar

10:00 - 10:15 What’s New in WHO 2016 Histological Classification of Prostatic Tumors

Ghazi Zaatari

10:15 - 10:30 What’s New in WHO 2016 Histomolecular Kidney Tumors Classification

Selim Nasser

10:30 - 11:15 Improving Continuum of Care in Metastatic RCC Patients Symposium Pfizer

Ali Shamseddine


11:45 - 12:00 What’s New in WHO 2016 Histomolecular Bladder Tumors Classification

Samah El Naderi

12:00 - 12:45 In the Age of Immunotherapy , Vinflunine remains the Mainstay for Advanced Bladder CancerSymposium Pierre Fabre

Joaquim Bellmunt

Moderator: Ali Shamseddine12:45 - 13:30 Weighing up First-Line Options: Choosing an appropriate

mRCC therapy; aligning on the needs of patients and physicians - Symposium Novartis

Emiliano Calvo


14:30 - 15:40 Neuro Endocrine Tumor14:30 - 14:50 New Classification of GI Neuroendocrine Tumors Ghazi Zaatari14:50- 15:10 Imaging and Therapy of Neuroendocrine Tumors in

Nuclear Medicine - Innovative AspectsMohamed Haidar

15:10 - 15:30 Chemotherapy Update in Non Pancreatic GI Neuroendocrine Tumors

Mustapha Tehfe

15:30 - 15:40 Discussion

15:40 - 16:20 Immunotherapy: What do we Expect?15:40 - 16:00 Immunotherapy in Breast Cancer Ahmad Awada16:00 - 16:20 Immunotherapy in GI Osama Rahma





(LSMO)

Day 3 | Saturday 01 April, 2017 Carthage Hall

09:00 - 13:00 Palliative Care in Cancer PatientIn Collaboration with the Order of Nurses in Lebanon

09:00 - 10:35 TBA TBA

Moderator: Hussein Abukhudair10:35 - 12:45 Understanding Pain & Palliative Care in Cancer Patients10:35 - 10:55 Caring for the Seriously Ill Patients Rana Yamout10:55 - 11:15 Opioids in Lebanon: What Do we Have & What Do we Need Rana Yamout


11:45 - 12:05 Breakthrough Pain Management Hussein Abukhudair12:05 - 12:25 Multi-Disciplinary Approach in Pain Management Hussein Abukhudair12:25 - 12:45 Palliative Care: Deep Dive into Chemo Induced Nausea &

VomitingGianluca Ballinari


14:15 - 16:15 Pharmacy SessionIn Collaboration with the Order of Pharmacy in Lebanon

14:15 - 14:45 Oncology Pharmacy Practice in Lebanon: Old Challenges, New Insights

Racha Hawasli

14:45 - 15:15 Palliative Care in Cancer Patients Aline Hajj15:15 - 15:45 The Growing Value of Community Pharmacists in Cancer

PatientsRhea Saad

15:45 - 16:15 Anti-PD1 Immunotherapy: A New Triumph in the Fight Against Cancer

Racha Karaky





(LSMO)

Notes



(LSMO)

4th FLOOR, QUBIC CENTER, DAOUD AMMOUN STREET, HORSH TABET - SIN EL FILP.O BOX: 90-361 BEIRUT, LEBANON | TEL: +961 1 510880/1/2/3 | FAX Ext. 121EMAIL: [email protected] | WEB: WWW.INFOMEDWEB.COM

Organised by:

The Lebanese Society of Medical Oncology (LSMO)would like to thank the following companies

for their contribution to the success of its annual congress

PLATINUM SPONSOR

GOLD SPONSORS

CONTRIBUTORS

th lebanese society of medical oncology(lsmo ... program.pdfon behalf of the lebanese society of...

Documents